APOL1 C-terminal variants may trigger kidney disease through interference with APOL3 control of actomyosin

Sophie Uzureau, Laurence Lecordier, Pierrick Uzureau, Dorle Hennig, Jonas H. Graversen, Fabrice Homble, Pepe Ekulu Mfutu, Fanny Oliveira Arcolino, Ana Raquel Ramos, Rita M. La Rovere, Tomas Luyten, Marjorie Vermeersch, Patricia Tebabi, Marc Dieu, Bart Cuypers, Stijn Deborggraeve, Marion Rabant, Christophe Legendre, Soren K. Moestrup, Elena LevtchenkoGeert Bultynck, Christophe Erneux, David Perez-Morga, Etienne Pays

Research output: Contribution to journalA1: Web of Science-articlepeer-review

16 Downloads (Pure)

Fingerprint

Dive into the research topics of 'APOL1 C-terminal variants may trigger kidney disease through interference with APOL3 control of actomyosin'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry